Outlook Therapeutics Inc. (NASDAQ: OTLK)
$2.1900
+0.0100 ( +0.46% ) 1.5K
Outlook Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing ONS-5010, a monoclonal antibody, or mAb, for various ophthalmic indications.
Market Data
Open
$2.1900
Previous close
$2.1800
Volume
1.5K
Market cap
$54.29M
Day range
$2.1800 - $2.1900
52 week range
$0.8700 - $12.8499
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 22, 2024 |
4 | Insider transactions | 1 | Mar 22, 2024 |
4 | Insider transactions | 1 | Mar 22, 2024 |
4 | Insider transactions | 1 | Mar 20, 2024 |
8-k | 8K-related | 14 | Mar 18, 2024 |
4 | Insider transactions | 1 | Mar 11, 2024 |
4 | Insider transactions | 1 | Mar 08, 2024 |
4 | Insider transactions | 1 | Mar 08, 2024 |
4 | Insider transactions | 1 | Mar 08, 2024 |
4 | Insider transactions | 1 | Mar 08, 2024 |